Meet the team.
Our interdisciplinary team transforming drug discovery.
Micrographia Bio was founded with the inspiration that all diseases deserve a cure. Being a part of the Company means being passionate about improving drug discovery and making medicines that matter.
Micrographia Bio is a founder-led company and composed of a world-class team including experts in molecular biology, chemistry, physics, optics and machine learning who are dedicated to delivering a new era of drug discovery.
Micrographia Bio is a founder-led company and composed of a world-class team including experts in molecular biology, chemistry, physics, optics and machine learning who are dedicated to delivering a new era of drug discovery.
Leadership
Meet our leadership team.
Julia Fan Li, PhD
Chris Thompson, PhD
Shaun McNulty, PhD
CEO & Co-Founder
CTO & Co-Founder
Chief Scientific Officer
Impatient optimist with deep expertise in building and scaling life sciences companies and creating new innovative finance asset classes ($108mm Global Health Investment Fund, part of GHIC). PhD Engineering University of Cambridge
Technologist with world-leading expertise in computer vision, robotics and disease biology. PhD Protein Signalling Imperial College London
Biochemist by training with 25+ years of drug discovery leadership. Played a key role in the development of two marketed medicines and has supported 11+ clinical trials, licensing of 5 projects and the development of 50+ candidates across various targets.
Scientific Advisory Board
Meet our Scientific Advisory Board.
Annalisa Jenkins,
MBBS, FRCP, OBE
Professor Ed Tate,
PhD
Kate Haviland,
MBA
Non-Executive Director,
Genomics England
Genomics England
Former CEO,
Blueprint Medicines
Blueprint Medicines
GSK Chair in Chemical Biology,
Imperial College London
Imperial College London
Former Head of R&D at Merck Serono, Global Head & SVP of Medical Affairs at Bristol-Myers Squibb, and CEO Dimension Therapeutics. Annalisa chairs and serves on the boards of several life sciences companies in the US and UK.
Most recent CEO and President of Blueprint Medicines where she also previously held the roles of COO and CBO. Kate chairs the boards of multiple life science companies in the US.
Satellite Group Leader at the Francis Crick Institute and GSK Chair in Chemical Biology. Ed is a Professor at Imperial College London and serves on the boards of multiple life sciences companies in the UK.
Alexander Moscho,
PhD
Deborah Dunsire,
MD
Professor Ralf Jungmann,
PhD
Former Chief Strategy Officer,
UCB
UCB
Professor and Chair for Molecular Physics, Ludwig Maximilian University
Former CEO of Lundbeck, Millenium and FORUM Pharmaceuticals
Former Operating Partner at Triton Partners and former member of UCB’s Executive Committee and General Manager of UK & Ireland for Bayer. Alexander is an active angel investor in transformational technologies.
Leading expert in molecular imaging and bionanotechnology. Ralf is known for his contributions to the development of super-resolution microscopy techniques and his work on DNA-PAINT.
Physician and biopharmaceutical executive with over 30 years experience in global drug development and pharmaceutical leadership. She serves on the boards of multiple biotech and life sciences companies globally.
Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
You can email us directly at
contact@micrographiabio.com
Micrographia Bio (122L)
Translation & Innovation Hub
84 Wood Lane
London, W12 0BZ
Please sign up here for subscribing to news & partnering opportunities.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.